A Longitudinal Study of Ebola Sequelae in Liberia
Author:
- The PREVAIL III Study GroupTGThe PREVAIL III Study Group
Top Cited Papers
Open Access
- 7 March 2019
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 380 (10) , 924-934
Abstract
Multiple health problems have been reported in survivors of Ebola virus disease (EVD). Attribution of these problems to the disease without a control group for analysis is difficult. We enrolled a cohort of EVD survivors and their close contacts and prospectively collected data on symptoms, physical examination findings, and laboratory results. A subset of participants underwent ophthalmologic examinations. Persistence of Ebola virus (EBOV) RNA in semen samples from survivors was determined. A total of 966 EBOV antibody–positive survivors and 2350 antibody-negative close contacts (controls) were enrolled, and 90% of these participants were followed for 12 months. At enrollment (median time to baseline visit, 358 days after symptom onset), six symptoms were reported significantly more often among survivors than among controls: urinary frequency (14.7% vs. 3.4%), headache (47.6% vs. 35.6%), fatigue (18.4% vs. 6.3%), muscle pain (23.1% vs. 10.1%), memory loss (29.2% vs. 4.8%), and joint pain (47.5% vs. 17.5%). On examination, more survivors than controls had abnormal abdominal, chest, neurologic, and musculoskeletal findings and uveitis. Other than uveitis (prevalence at enrollment, 26.4% vs. 12.1%; at year 1, 33.3% vs. 15.4%), the prevalence of these conditions declined during follow-up in both groups. The incidence of most symptoms, neurologic findings, and uveitis was greater among survivors than among controls. EBOV RNA was detected in semen samples from 30% of the survivors tested, with a maximum time from illness to detection of 40 months. A relatively high burden of symptoms was seen in all participants, but certain symptoms and examination findings were more common among survivors. With the exception of uveitis, these conditions declined in prevalence during follow-up in both groups. Viral RNA in semen persisted for a maximum of 40 months. (Funded by the National Institute of Allergy and Infectious Diseases and the National Eye Institute; PREVAIL III ClinicalTrials.gov number, NCT02431923.)Keywords
Funding Information
- National Institute of Allergy and Infectious Diseases (Leidos subcontract 16X054, NIAIDprotocol 15-I-N122)
This publication has 24 references indexed in Scilit:
- Long-term sequelae after Ebola virus disease in Bundibugyo, Uganda: a retrospective cohort studyThe Lancet Infectious Diseases, 2015
- Study of Ebola Virus Disease Survivors in Guinea: Table 1.Clinical Infectious Diseases, 2015
- Long-Term Clinical and Neuropsychological Outcomes of West Nile Virus InfectionClinical Infectious Diseases, 2006
- Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort studyBMJ, 2006
- Health‐Related Quality of Life and Posttraumatic Stress Disorder among Survivors of an Outbreak of Legionnaires DiseaseClinical Infectious Diseases, 2002
- Caring for the survivors of Uganda's Ebola epidemic one year onThe Lancet, 2001
- Clinical, Virologic, and Immunologic Follow‐Up of Convalescent Ebola Hemorrhagic Fever Patients and Their Household Contacts, Kikwit, Democratic Republic of the CongoThe Journal of Infectious Diseases, 1999
- Late Ophthalmologic Manifestations in Survivors of the 1995 Ebola Virus Epidemic in Kikwit, Democratic Republic of the CongoThe Journal of Infectious Diseases, 1999
- Posttraumatic Stress Disorder in the National Comorbidity SurveyArchives of General Psychiatry, 1995
- Blindness from uveitis in a hospital population in Sierra Leone.British Journal of Ophthalmology, 1994